• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小分子抗菌肽模拟物作为一种有前途的治疗方法来对抗细菌耐药性。

Small Molecular Mimetics of Antimicrobial Peptides as a Promising Therapy To Combat Bacterial Resistance.

机构信息

Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, Zhejiang 310058, P. R. China.

Department of Chemistry, University of South Florida, 4202 E. Fowler Avenue, Tampa, Florida 33620, United States.

出版信息

J Med Chem. 2023 Feb 23;66(4):2211-2234. doi: 10.1021/acs.jmedchem.2c00757. Epub 2023 Feb 5.

DOI:10.1021/acs.jmedchem.2c00757
PMID:36739538
Abstract

Clinically, antibiotics are widely used to treat infectious diseases; however, excessive drug abuse and overuse exacerbate the prevalence of drug-resistant bacterial pathogens, making the development of novel antibiotics extremely difficult. Antimicrobial peptide (AMP) is one of the most promising candidates for overcoming bacterial resistance owing to its unique structure and mechanism of action. This study examines the development of small molecular mimetics of AMPs over the past two decades. These mimetics can selectively disrupt membranes, which are the characteristic antibacterial mechanism of AMPs. In addition, the advantages and disadvantages of small AMP mimetics are discussed. The small molecular mimetics of AMPs are anticipated to garner interest and investment in discovering new antibiotics. This Perspective will assist in revitalizing the golden age of antibiotics in the current era of combating bacterial resistance.

摘要

临床上,抗生素被广泛用于治疗传染病;然而,过度滥用和过度使用会加剧耐药细菌病原体的流行,使得新型抗生素的开发变得极其困难。抗菌肽 (AMP) 是克服细菌耐药性最有前途的候选物之一,因为其独特的结构和作用机制。本研究考察了过去二十年中 AMP 的小分子模拟物的发展。这些模拟物可以选择性地破坏细胞膜,这是 AMP 的特征性抗菌机制。此外,还讨论了小分子 AMP 模拟物的优缺点。预计 AMP 的小分子模拟物将引起人们对发现新型抗生素的兴趣和投资。本观点将有助于在当前对抗细菌耐药性的时代重振抗生素的黄金时代。

相似文献

1
Small Molecular Mimetics of Antimicrobial Peptides as a Promising Therapy To Combat Bacterial Resistance.小分子抗菌肽模拟物作为一种有前途的治疗方法来对抗细菌耐药性。
J Med Chem. 2023 Feb 23;66(4):2211-2234. doi: 10.1021/acs.jmedchem.2c00757. Epub 2023 Feb 5.
2
Antimicrobial peptides for combating drug-resistant bacterial infections.用于对抗耐药细菌感染的抗菌肽。
Drug Resist Updat. 2023 May;68:100954. doi: 10.1016/j.drup.2023.100954. Epub 2023 Mar 1.
3
Antimicrobial peptides: Opportunities and challenges in overcoming resistance.抗菌肽:克服耐药性的机遇与挑战。
Microbiol Res. 2024 Sep;286:127822. doi: 10.1016/j.micres.2024.127822. Epub 2024 Jun 26.
4
Antimicrobial Peptides: the Achilles' Heel of Antibiotic Resistance?抗菌肽:抗生素耐药性的阿喀琉斯之踵?
Probiotics Antimicrob Proteins. 2019 Jun;11(2):370-381. doi: 10.1007/s12602-018-9465-0.
5
Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?先天免疫系统抗菌肽与传统抗生素联合应用——一种应对抗生素耐药性的新方法?
Front Cell Infect Microbiol. 2019 Apr 30;9:128. doi: 10.3389/fcimb.2019.00128. eCollection 2019.
6
Mechanisms and consequences of bacterial resistance to antimicrobial peptides.抗菌肽耐药性的机制和后果。
Drug Resist Updat. 2016 May;26:43-57. doi: 10.1016/j.drup.2016.04.002. Epub 2016 Apr 20.
7
Antimicrobial peptide-based strategies to overcome antimicrobial resistance.基于抗菌肽的策略来克服抗菌耐药性。
Arch Microbiol. 2024 Sep 23;206(10):411. doi: 10.1007/s00203-024-04133-x.
8
Antimicrobial Peptide Synergies for Fighting Infectious Diseases.抗菌肽协同作用对抗感染性疾病。
Adv Sci (Weinh). 2023 Sep;10(26):e2300472. doi: 10.1002/advs.202300472. Epub 2023 Jul 5.
9
Highly Potent Antibacterial Organometallic Peptide Conjugates.高效能抗菌金属有机肽缀合物。
Acc Chem Res. 2017 Oct 17;50(10):2510-2518. doi: 10.1021/acs.accounts.7b00282. Epub 2017 Sep 27.
10
Synergism between Host Defence Peptides and Antibiotics Against Bacterial Infections.宿主防御肽与抗生素协同抗细菌感染。
Curr Top Med Chem. 2020;20(14):1238-1263. doi: 10.2174/1568026620666200303122626.

引用本文的文献

1
Role of Structural Modifications in Peptidomimetic Compounds as Potential Antimicrobial Agents against and : Balancing Bioavailability, Safety, and Antimicrobial Activity.结构修饰在拟肽化合物作为抗[具体对象1]和[具体对象2]潜在抗菌剂中的作用:平衡生物利用度、安全性和抗菌活性。
ACS Omega. 2025 Jul 22;10(30):33435-33460. doi: 10.1021/acsomega.5c03775. eCollection 2025 Aug 5.
2
Eradication of MRSA biofilms using amphiphilic cationic coumarin derivatives.使用两亲性阳离子香豆素衍生物根除耐甲氧西林金黄色葡萄球菌生物膜
RSC Adv. 2025 Jul 18;15(31):25510-25513. doi: 10.1039/d5ra04358a. eCollection 2025 Jul 15.
3
A review on small molecular mimics of antimicrobial peptides with an emphasis on the structure-activity relationship perspective.
一篇关于抗菌肽小分子模拟物的综述,重点关注构效关系视角。
RSC Med Chem. 2025 Jun 24. doi: 10.1039/d5md00407a.
4
Design and synthesis of coumarin-based amphoteric antimicrobials with biofilm interference and immunoregulation effects.具有生物膜干扰和免疫调节作用的香豆素基两性抗菌剂的设计与合成
RSC Med Chem. 2024 Oct 22. doi: 10.1039/d4md00721b.
5
Nucleus-forming jumbophage PhiKZ therapeutically outcompetes non-nucleus-forming jumbophage Callisto.形成细胞核的巨型噬菌体PhiKZ在治疗上比不形成细胞核的巨型噬菌体Callisto更具竞争力。
iScience. 2024 Apr 18;27(5):109790. doi: 10.1016/j.isci.2024.109790. eCollection 2024 May 17.
6
Impacts of Hydrophobic Mismatch on Antimicrobial Peptide Efficacy and Bilayer Permeabilization.疏水不匹配对抗菌肽功效及双层膜通透性的影响
Antibiotics (Basel). 2023 Nov 14;12(11):1624. doi: 10.3390/antibiotics12111624.
7
An Update Review of Approaches to Multiple Action-Based Antibacterials.基于多种作用机制的抗菌药物研究进展综述
Antibiotics (Basel). 2023 May 6;12(5):865. doi: 10.3390/antibiotics12050865.
8
To Fold or Not to Fold: Diastereomeric Optimization of an α-Helical Antimicrobial Peptide.折叠还是不折叠:一种 α-螺旋抗菌肽的非对映体优化。
J Med Chem. 2023 Jun 8;66(11):7570-7583. doi: 10.1021/acs.jmedchem.3c00460. Epub 2023 May 25.
9
Tuning the Anthranilamide Peptidomimetic Design to Selectively Target Planktonic Bacteria and Biofilm.调整邻氨基苯甲酰胺肽模拟物设计以选择性靶向浮游细菌和生物膜。
Antibiotics (Basel). 2023 Mar 15;12(3):585. doi: 10.3390/antibiotics12030585.